AIMZ Investment Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-51,372
| Closed | -$175K | – | 115 |
|
|
2023
Q3 | $175K | Sell |
51,372
-750
| -1% | -$2.55K | 0.08% | 109 |
|
|
2023
Q2 | $383K | Sell |
52,122
-288
| -0.5% | -$2.12K | 0.16% | 85 |
|
|
2023
Q1 | $543K | Sell |
52,410
-180
| -0.3% | -$1.87K | 0.24% | 77 |
|
|
2022
Q4 | $621K | Sell |
52,590
-17,061
| -24% | -$201K | 0.29% | 69 |
|
|
2022
Q3 | $1.46M | Sell |
69,651
-937
| -1% | -$19.7K | 0.74% | 48 |
|
|
2022
Q2 | $2.19M | Sell |
70,588
-37
| -0.1% | -$1.15K | 1.05% | 37 |
|
|
2022
Q1 | $2.9M | Sell |
70,625
-3,250
| -4% | -$133K | 1.19% | 27 |
|
|
2021
Q4 | $3.21M | Buy |
73,875
+12,825
| +21% | +$557K | 1.25% | 28 |
|
|
2021
Q3 | $3.06M | Buy |
61,050
+3,750
| +7% | +$188K | 1.38% | 23 |
|
|
2021
Q2 | $3.61M | Buy |
+57,300
| New | +$3.61M | 1.62% | 18 |
|